Durham, NC – According to filings with the U.S. Securities and Exchange Commission, Boragen is raising $2,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Roger Kemble played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Boragen

Boragen is a small molecule development company focused on leveraging the unique chemical properties of Boron chemistry, both in crop protection and animal health. Advances made by Boragen will fill key innovation gaps, helping meet global agricultural production needs while upholding stewardship practices..

To learn more about Boragen, visit http://boragenbio.com/

Contact:
Roger Kemble, Chief Executive Officer
919-680-5227

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved